Company Filing History:
1 out of 31 
1 out of 810 
1 out of 48 Years Active: 2001-2013
Title: Akiva Vexler: Innovator in Immunotoxin Production and Tissue Examination
Introduction
Akiva Vexler is a notable inventor based in Hod Hasharon, Israel. He has made significant contributions to the fields of biotechnology and medical research, holding 2 patents that showcase his innovative spirit and technical expertise.
Latest Patents
One of Vexler's latest patents is titled "Recombinant fusion protein and polynucleotide construct for immunotoxin production." This invention relates to a polynucleotide construct encoding a fusion protein that consists of a domain binding the immunoglobulin Fc region, genetically fused to a truncated form of exotoxin A (PE). The invention discloses the fusion protein, ZZ-PE38, and provides immunotoxins formed from complexes of the fusion protein with antibodies for targeted cell killing.
Another significant patent is the "Device for examining viscoelasticity of a living or artificial tissue." This device includes a probe designed to examine the viscoelasticity and anisotropy of an area of an external layer of living or artificial tissue. It comprises an assembly with at least one group of piezoelectric spaced-apart transducers, where one transducer acts as a transmitter and at least one other as a receiver. The assembly is movable both axially and angularly, allowing for controlled examination of tissue properties.
Career Highlights
Throughout his career, Akiva Vexler has worked with prominent organizations such as Hadasit Medical Research Services and Development Company and Tel Aviv University. His work in these institutions has contributed to advancements in medical research and technology.
Collaborations
Vexler has collaborated with notable professionals in his field, including Raphael Gorodetsky and Igor Polyansky. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Akiva Vexler's contributions to immunotoxin production and tissue examination highlight his role as a significant innovator in biotechnology. His patents reflect a commitment to advancing medical science and improving healthcare solutions.